The global healthcare and pharmaceutical landscape is evolving faster than ever. As we move into 2026, changing policies, breakthrough innovations, and rapid market changes are reshaping how companies plan, launch, and compete, unveiling new opportunities. As launch success becomes harder to achieve and loss of exclusivity (LOE) pressure intensifies across key therapy areas, commercial teams are facing more uncertainty than ever.

Join our flagship Early Bird webinar to unpack IQVIA’s latest 2025 data and discover the trends set to shape the year ahead. From the rise of obesity treatments to major shifts in therapeutic administration and impending LOE, this session will equip you with the insights needed to navigate this rapidly evolving environment.

In this data-driven session, our expert will:

• Break down 2025 global market trends, including sales value and volume dynamics, therapy area evolution, promotional mix, and launch performance.
• Deep dive into key therapy areas —Obesity, Oncology, and Immunology — to assess growth areas, forecasts, and patient-centered metrics.
• Explore the biosimilar landscape, including regulatory considerations and the competitive landscape.
• Look ahead to 2026 and beyond, revealing the forces expected to shape the future pharmaceutical market.

Unlock early access to IQVIA’s latest global pharmaceutical metrics and leave with actionable intelligence to support strategic planning, portfolio decisions, and commercial execution.

Don’t miss the first look at 2025’s most significant trends — register today.